Growth Inhibition and Apoptosis Induction by (+)-Cyanidan-3-ol in Hepatocellular Carcinoma

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Monga, Jitender ^a   Pandit, Saurabh ^a   Chauhan, Rajinder Singh ^a   Chauhan, Chetan Singh ^b   Chauhan, Shailender Singh ^c   Sharma, Manu ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

^b Bhupal Nobles' College of Pharmacy   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CATECHIN; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; PROTEIN MDM2; PROTEIN P53; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AP 1 GENE; APOPTOSIS; ARTICLE; BAX GENE; CANCER INHIBITION; CANCER PREVENTION; CASPASE 3 GENE; CASPASE 7 GENE; CASPASE 8 GENE; CASPASE 9 GENE; CELL PROLIFERATION; CELL STRAIN HEPG2; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOCHROME C GENE; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LIVER INJURY; MALE; MARKER GENE; MDM2 GENE; MOUSE; NF KAPPA B GENE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; OXIDATIVE STRESS; P65 GENE; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

EID: 84880817624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068710     Document Type: Article

References (60)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917. doi:10.1002/ijc.25516. PubMed: 21351269.
2. Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, et al. (2006) Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 24: 4293-4300. doi:10.1200/JCO.2005.01.3441. PubMed: 16908937.
3. Ruhul Amin ARM, Kucuk O, Khuri ER, Shin DM, (2009) Perspectives for cancer prevention with natural compounds. J Clin Oncol 27: 2712-2725. doi:10.1200/JCO.2008.20.6235. PubMed: 19414669.
4. Barnes S, Prasain J, (2005) Current progress in the use of traditional medicine and nutraceuticals. Curr Opin Plant Biol 8: 324-328. doi:10.1016/j.pbi.2005.03.010. PubMed: 15860430.
5. Monga J, Chauhan CS, Sharma M, (2011) Human epithelial carcinoma cytotoxicity and inhibition of DMBA/TPA induced squamous cell carcinoma in Balb/c mice by Acacia catechu heartwood. J Pharm Pharmacol 63: 1470-1482. doi:10.1111/j.2042-7158.2011.01354.x. PubMed: 21988428.
6. Monga J, Chauhan CS, Sharma M, (2012) Human breast adenocarcinoma cytotoxicity and modulation of 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma in Balb/c mice by Acacia catechu heartwood. Integr Cancer Ther, [E pub ahead].
7. Lotito BS, Fraga CG, (1998) CD-3 prevents human plasma oxidation. Free Radic Biol Med 24: 435-441. doi:10.1016/S0891-5849(97)00276-1. PubMed: 9438556.
8. Rage N, Dahanukar S, Karandikar SM, (1984) Hepatoprotective effect of cyanidanol against carbon tetrachloride induced liver damage. Indian Drugs 22: 556-560.
9. Guruvayoorappan C, Kuttan G, (2008) CD-3 inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-α in LPS-stimulated macrophages. Innate Immun 14: 160-174. doi:10.1177/1753425908093295. PubMed: 18562575.
10. Anderson R, Smit MJ, Van Rensburg CE, (1993) Lysophospholipid-mediated inhibition of Na+, K(+)-adenosine triphosphatase is a possible mechanism of immunorepressive activity of cyclosporin A. Mol Pharmacol 44: 605-614. PubMed: 8396720.
11. Denizot F, Lang R, (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271-277. doi:10.1016/0022-1759(86)90368-6. PubMed: 3486233.
12. Vanicha V, Kanyawim K, (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature 1: 1112-1116. PubMed: 17406391.
13. Saad S, Dakwar O, Said G, Abu-Hijleh G, Battah FA, et al. (2006) Evaluation of medicinal plant hepatotoxicity in co-cultures of hepatocytes and monocytes. Evid Based Complement Alternat Med 3: 93-98. doi:10.1093/ecam/nel002. PubMed: 16550229.
14. Duarte RA, Mello ER, Araki C, Bolzani VS, Siqueirs Silva DH, et al. (2010) Alkaloids extracted from Pterogyne nitens induce apoptosis in malignant breast cell line. Tumor Biol 31: 513-522. doi:10.1007/s13277-010-0064-2. PubMed: 20700682.
15. Jimenez PC, Wilke DV, Takeara R, Lotufo TM, Pessoa C, et al. (2008) Cytotoxicity activity of a dichloromethane extract and fractions obtained from Eudistoma vannamei (Tunicata: Ascidiacea). Comp Biochem Physiol A Mol Integr Physiol 151: 391-398. doi:10.1016/j.cbpa.2007.02.018. PubMed: 17400012.
16. Kurita-Ochiai T, Fukushima K, Ochiai K, (1999) Lipopolysaccharide stimulates butyric acid-induced apoptosis in human peripheral blood mononuclear cells. Infect Immun 67: 22-29. PubMed: 9864191.
17. Perandones CE, Illera VA, Peckham D, Stunz LL, Ashman RF, (1993) Regulation of apoptosis in vitro in mature spleen T cells. J Immunol 151: 3521-3529. PubMed: 8376790.
18. Walker PR, Kokileva L, LeBlanc J, Sikorska M, (1993) Detection of the initial stages of DNA fragmentation in apoptosis. BioTechniques 15: 1032-1040. PubMed: 8292335.
19. Liao PC, Lieu PC, (2005) Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sci 76: 1623-1639. doi:10.1016/j.lfs.2004.09.021. PubMed: 15680171.
20. Singh BN, Singh BR, Sarma BK, Singh HB, (2009) Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark. Chem Biol Interact 181: 20-28. doi:10.1016/j.cbi.2009.05.007. PubMed: 19446540.
21. Reitman S, Frankel SA, (1957) A colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28: 3856-3863.
22. Bergmeyer HU, Bernt E, (1974) Aminotransferases and related enzymes. In: Bergmeyer HU, eds. Methods of Enzymatic Analysis. pp. pp. 735-763.
23. Szasz G, (1976) Reaction rate method for gamma glutamyl transferase activity in serum. Clin Chem 22: 2031-2055. PubMed: 1000801.
24. Plucinsky MC, Riley WM, Prorok JJ, Alhadeff JA, (1986) Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer 58: 2680-2685. doi:10.1002/1097-0142(19861215)58:12. PubMed: 3779617.
25. Katopodis N, Hirshaut Y, Geller NL, Stock CC, (1982) Lipid-associated sialic acid test for the detection of human cancer. Cancer Res 42: 5270-5275. PubMed: 7139630.
26. Wills ED, (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99: 667-676. PubMed: 5964963.
27. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, et al. (1982) Analysis of nitrate, nitrite, and [15n] nitrate in biological fluids. Anal Biochem 126: 131-138. doi:10.1016/0003-2697(82)90118-X. PubMed: 7181105.
28. Kono Y, (1978) Generation of superoxide radicals during auto-oxidation of hydroxyl amine and an assay of superoxide dismutase. Arch Biochem Biophys 186: 189-195. doi:10.1016/0003-9861(78)90479-4. PubMed: 24422.
29. Aebi H, (1984) Catalase in vitro. Methods Enzymol 105: 121-126. doi:10.1016/S0076-6879(84)05016-3. PubMed: 6727660.
30. Flohé L, Günzler WA, (1984) Assays of glutathione peroxidase. Methods Enzymol 105: 114-121. doi:10.1016/S0076-6879(84)05015-1. PubMed: 6727659.
31. Carlberg I, Mannervik B, (1985) Glutathione reductase. Methods Enzymol 113: 484-490. doi:10.1016/S0076-6879(85)13062-4. PubMed: 3003504.
32. Warholm M, Guthenberg C, Von Bahr C, Mannervik B, (1985) Gluthathione transferases from human liver. Methods Enzymol 113: 499-504. doi:10.1016/S0076-6879(85)13065-X. PubMed: 3003505.
33. Sedlak J, Lindsay RH, (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25: 192-205. doi:10.1016/0003-2697(68)90092-4. PubMed: 4973948.
34. Ellman GL, (1959) Tissue sulfhydryl groups. Arch Biochem Bios Phys 82: 70-77. doi:10.1016/0003-9861(59)90090-6. PubMed: 13650640.
35. Hickman JA, (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-129. doi:10.1007/BF00048059. PubMed: 1327566.
36. Fink SL, Cookson BT, (2005) Apoptosis, pyroptosis, & necrosis: mechanistic description of dead & dying eukaryotic cells. Infect Immun 73: 1907-1916. doi:10.1128/IAI.73.4.1907-1916.2005. PubMed: 15784530.
37. Ariffin SHZ, Wan Omar WH, Ariffin ZZ, Safian MF, Senafi S, Abdul Wahab RM, (2009) Intrinsic anticarcinogenic effects of Piper sarmentosum ethanolic extract on a human hepatoma cell line. Cancer Cell Int 9: 6. doi:10.1186/1475-2867-9-6. PubMed: 19257877.
38. Rao GM, Rao CV, Pushpangadan P, Annie S, (2006) Hepatoprotective effects of rubiadin, a major constituent of Rubiá cordifolia Linn. J Ethnopharmacol 103: 484-490. doi:10.1016/j.jep.2005.08.073. PubMed: 16213120.
39. Vásquez-Garzón VR, Arellanes-Robledo J, García-Román R, Aparicio-Rautista DI, Villa-Treviño S, (2009) Inhibition of reactive oxygen species and preneoplastic lesions by quercetin through an antioxidant defense mechanism. Free Radic Res 43: 128-137. doi:10.1080/10715760802626535. PubMed: 19115120.
40. Esme H, Cemek M, Sezer M, Saglam H, Demir A, et al. (2008) High levels of oxidative stress in patients with advanced lung cancer. Respirology 13: 112-116. doi:10.1111/j.1440-1843.2007.01212.x. PubMed: 18197920.
41. Ferreccio C, Gonzalez PC, Milosavjlevic SV, Marshall GG, Sancha AM, (1998) Lung cancer and arsenic exposure in drinking water: a case control study in northern Chile. Cad Saude Publica 14: 193-198. doi:10.1590/S0102-311X1998000100028.
42. Bitensky L, (1990) Glutathione: Chemical, Biochemical and Medical Aspects. Cell Biochem Funct 8: 139. doi:10.1002/cbf.290080216.
43. Dasgupta T, Banerjee S, Yadava PK, Rao AR, (2004) Chemopreventive potential of Azadirachta indica (Neem) leaf extract in murine carcinogenesis model systems. J Ethnopharmacol 92: 23-36. doi:10.1016/j.jep.2003.12.004. PubMed: 15099843.
44. Chen LH, Xi S, Cohen DA, (1995) Liver antioxidant defenses in mice fed ethanol and the AIN-76A diet. Alcohol 12: 453-457. doi:10.1016/0741-8329(95)00030-U. PubMed: 8519441.
45. Jenkins RR, Goldfarb A, (1993) Introduction: oxidant stress, aging and exercise. Med Sci Sports Exerc 25: 210-212. PubMed: 8450723.
46. Łuczaj W, Skrzydlewska E, (2004) Antioxidant properties of black tea in alcohol intoxication. Food Chem Toxicol 42: 2045-2051. doi:10.1016/j.fct.2004.08.009. PubMed: 15500941.
47. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, et al. (1990) Glutathione peroxidases, superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech Aging Dev 51: 283-297. doi:10.1016/0047-6374(90)90078-T. PubMed: 2308398.
48. Chandra R, Aneja R, Rewal C, Konduri R, Dass SK, et al. (2000) An opium alkaloid-papaverine ameliorates ethanol-induced hepatotoxicity: diminution of oxidative stress. Indian J Clin Biochem 15: 155-160. doi:10.1007/BF02883745. PubMed: 23105258.
49. Pollak N, Dölle C, Ziegler M, (2007) The power to reduce: pyridine nucleotides-small molecules with a multitude of functions. Biochem J 402: 205-218. doi:10.1042/BJ20061638. PubMed: 17295611.
50. Sen CK, (1998) Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55: 1747-1758. doi:10.1016/S0006-2952(97)00672-2. PubMed: 9714292.
51. Maximov GK, Maximov KG, (2008) The role of p53 tumor-suppressor protein in apoptosis and carcinogenesis. Biotechnol Biotechnol Equip 22: 664-668.
52. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR, (1998) The p53 network. J Biol Chem 273: 1-4. doi:10.1074/jbc.273.1.1. PubMed: 9417035.
53. Mowat MR, (1998) p53 in tumor progression: life, death and everything. Adv Cancer Res 74: 25-48. doi:10.1016/S0065-230X(08)60764-2. PubMed: 9561266.
54. Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J, (2011) A p53-independent role of Mdm2 in estrogen mediated activation of breast cancer cell proliferation. Breast Cancer Res; 13: R3. doi:10.1186/bcr2955. PubMed: 21223569.
55. Shangary S, Wang S, (2008) Targeting the MDM2-p53 Interaction for Cancer Therapy. Clin Cancer Res; 14: 5318-5324. doi:10.1158/1078-0432.CCR-07-5136. PubMed: 18765522.
56. Ashkenazi A, Herbst RS, (2008) To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 118: 1979-1990. doi:10.1172/JCI34359. PubMed: 18523647.
57. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, et al. (2009) Apoptosis and cancer: mutations within caspase genes. J Med Genet 46: 497-510. doi:10.1136/jmg.2009.066944. PubMed: 19505876.
58. Shaulian E, Karin M, (2001) AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400. doi:10.1038/sj.onc.1204383. PubMed: 11402335.
59. Bellas RE, FitzGerald MJ, Fausto N, Sonenshein GE, (1997) Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am J Pathol 151: 891-896. PubMed: 9327720.
60. Angel P, Karin M, (1991) The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157. PubMed: 1751545.